Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore Medical Dialogues Bureau24 July 2019 9:30 AM ISTThe firm's India business was up nine per cent year-on-year to Rs 907 crore for the quarter. The US revenues at Rs 376 crore were up by 13 per cent...
Sanofi strikes deal for US rights to Roche Tamiflu Medical Dialogues Bureau24 July 2019 9:15 AM ISTUnder the terms of the agreement, Sanofi will be responsible for leading FDA negotiations for the OTC switch and subsequent exclusive marketing,...
Revamped OxyContin was supposed to reduce abuse, but has it? Medical Dialogues Bureau24 July 2019 9:00 AM ISTThere's just one problem: Neither the company that makes OxyContin nor the FDA has allowed the experts to see data on whether it reduces...
Doctors should prescribe only generic medicines: CDSCO Committee Medical Dialogues Bureau23 July 2019 5:36 PM ISTThe generic medicines are at least 90 per cent cheaper than branded medicines. There are nearly 600 types of generic medicines and about 23 kinds of...
Cipla subsidiary gets USFDA nod for generic version of Lyrica Medical Dialogues Bureau23 July 2019 9:55 AM ISTCipla said the approved product, Pregabalin Capsules are a generic therapeutic equivalent version of Pfizer's Lyrica.New Delhi: Drug major Cipla...
GSK Pharma Q1 net profit up 35 percent at Rs 113 crore in FY20 Medical Dialogues Bureau23 July 2019 9:45 AM ISTMumbai: GlaxoSmithKline (GSK) Pharmaceuticals on Monday announced a 35 per cent jump in its net profit to Rs 113.5 crore during the first quarter of...
Laurus Labs, Rising Pharma launches neuropathic pain capsules in US Medical Dialogues Bureau23 July 2019 9:30 AM ISTRising Pharmaceuticals has launched a generic version of Lyrica capsules, in the strengths of 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and...
Gilead licenses respiratory, herpes antiviral research programs from Novartis Medical Dialogues Bureau23 July 2019 9:15 AM ISTUnder the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets....
Bayer sells Dr Scholls footcare brand to US firm for USD 585 million Medical Dialogues Bureau23 July 2019 9:00 AM ISTBayer, whose stock has slumped amid lawsuits over an alleged cancer-causing effect of its Roundup weed killer, struck a deal in May to sell the US sun...
Government BANS use of decade old antibiotic COLISTIN in animal feeding, fishing Farhat Nasim22 July 2019 3:24 PM ISTNew Delhi: Through a recent Gazette notification, the Union Health Ministry has imposed a ban on popular antibiotic Colistin and its formulations in...
Different claims used by PATANJALI for marketing in India and abroad: USFDA Medical Dialogues Bureau22 July 2019 1:44 PM IST"I observed that the 'Bel Sharbat' and 'Gulab Sharbat' products are sold under the PATANJALI brand name for domestic (India) and international (USA)...
Dr Reddys closes sale of US rights for neurology products Tosymra, Zembrace Symtouch Medical Dialogues Bureau22 July 2019 12:31 PM ISTUnder the agreement, Dr Reddy's sold its US and select territory rights for Zembrace Symtouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan...
